- Home
- NBTB vs CPRX Comparison
NBTB vs CPRX Comparison
Compare NBTB & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTB
- CPRX
- Stock Information
- Founded
- NBTB 1856
- CPRX 2002
- Country
- NBTB United States
- CPRX United States
- Employees
- NBTB N/A
- CPRX N/A
- Industry
- NBTB Major Banks
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- NBTB Finance
- CPRX Health Care
- Exchange
- NBTB Nasdaq
- CPRX Nasdaq
- Market Cap
- NBTB 2.3B
- CPRX 2.6B
- IPO Year
- NBTB N/A
- CPRX 2006
- Fundamental
- Price
- NBTB $42.77
- CPRX $20.02
- Analyst Decision
- NBTB Buy
- CPRX Strong Buy
- Analyst Count
- NBTB 3
- CPRX 5
- Target Price
- NBTB $52.33
- CPRX $33.20
- AVG Volume (30 Days)
- NBTB 154.9K
- CPRX 1.5M
- Earning Date
- NBTB 10-27-2025
- CPRX 11-05-2025
- Dividend Yield
- NBTB 3.46%
- CPRX N/A
- EPS Growth
- NBTB 7.37
- CPRX 183.96
- EPS
- NBTB 2.77
- CPRX 1.65
- Revenue
- NBTB $591,283,000.00
- CPRX $558,499,000.00
- Revenue This Year
- NBTB $27.02
- CPRX $16.51
- Revenue Next Year
- NBTB $11.44
- CPRX $9.58
- P/E Ratio
- NBTB $15.40
- CPRX $12.10
- Revenue Growth
- NBTB 14.42
- CPRX 28.55
- 52 Week Low
- NBTB $37.31
- CPRX $19.15
- 52 Week High
- NBTB $52.44
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- NBTB 46.35
- CPRX 46.35
- Support Level
- NBTB $41.89
- CPRX $19.66
- Resistance Level
- NBTB $43.79
- CPRX $20.52
- Average True Range (ATR)
- NBTB 0.85
- CPRX 0.67
- MACD
- NBTB -0.23
- CPRX 0.03
- Stochastic Oscillator
- NBTB 25.96
- CPRX 42.08
About NBTB NBT Bancorp Inc.
NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).